Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

Phamaniaga Bhd has the capacity to manufacture two million doses of Covid-19 vaccine developed by China’s Sinovac Life Sciences Co Ltd per month beginning March this year.

Group managing director Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga's wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong.

He said the group would invest RM3 million to retrofit the plant...